Competition between APOE and tau protein for LRP1 receptor binding, which is involved in AD pathophysiology, has been recently demonstrated as a mechanism for reduction of tau uptake and its subsequent spread within the CNS [163]. Here, MAPT is linked to Alzheimer disease.